SI1884234T1 - Profilaktično ali terapevtsko sredstvo za kornealno in konjunktivalno motnjo - Google Patents

Profilaktično ali terapevtsko sredstvo za kornealno in konjunktivalno motnjo

Info

Publication number
SI1884234T1
SI1884234T1 SI200631399T SI200631399T SI1884234T1 SI 1884234 T1 SI1884234 T1 SI 1884234T1 SI 200631399 T SI200631399 T SI 200631399T SI 200631399 T SI200631399 T SI 200631399T SI 1884234 T1 SI1884234 T1 SI 1884234T1
Authority
SI
Slovenia
Prior art keywords
corneal
prophylactic
therapeutic agent
conjunctival disorder
conjunctival
Prior art date
Application number
SI200631399T
Other languages
English (en)
Inventor
Atsushi Santen Pharmaceutical Co Ltd Yoshida
Shinichirou Santen Pharmaceutical Co Ltd Hirai
Masatsugu Santen Pharmaceutical Co Ltd Nakamura
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of SI1884234T1 publication Critical patent/SI1884234T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SI200631399T 2005-05-17 2006-05-17 Profilaktično ali terapevtsko sredstvo za kornealno in konjunktivalno motnjo SI1884234T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005143477 2005-05-17
PCT/JP2006/309797 WO2006123676A1 (ja) 2005-05-17 2006-05-17 角結膜障害の予防または治療剤
EP06746500A EP1884234B1 (en) 2005-05-17 2006-05-17 Prophylactic or therapeutic agent for corneal and conjunctival disorder

Publications (1)

Publication Number Publication Date
SI1884234T1 true SI1884234T1 (sl) 2012-10-30

Family

ID=37431248

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200631399T SI1884234T1 (sl) 2005-05-17 2006-05-17 Profilaktično ali terapevtsko sredstvo za kornealno in konjunktivalno motnjo

Country Status (14)

Country Link
US (2) US8222283B2 (sl)
EP (1) EP1884234B1 (sl)
KR (1) KR101286883B1 (sl)
CN (1) CN101175487B (sl)
CA (1) CA2608457C (sl)
CY (1) CY1113161T1 (sl)
DK (1) DK1884234T3 (sl)
ES (1) ES2389566T3 (sl)
NO (1) NO20076398L (sl)
PL (1) PL1884234T3 (sl)
PT (1) PT1884234E (sl)
RU (1) RU2406499C2 (sl)
SI (1) SI1884234T1 (sl)
WO (1) WO2006123676A1 (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2406499C2 (ru) 2005-05-17 2010-12-20 Сантен Фармасьютикал Ко., Лтд. Профилактическое или терапевтическое средство для лечения кератоконъюнктивитных нарушений
ES2370751T3 (es) * 2007-05-25 2011-12-22 Santen Pharmaceutical Co., Ltd Agente profiláctico o terapéutico para la degeneración macular asociada a la edad.
KR20100124756A (ko) * 2008-02-28 2010-11-29 산텐 세이야꾸 가부시키가이샤 시신경 장해를 동반하는 안질환의 예방 또는 치료제
RU2459615C1 (ru) * 2011-03-05 2012-08-27 Илья Александрович Марков Глазные капли для лечения болезни сухого глаза
EP2783689B1 (en) 2011-11-24 2019-09-25 Toyo Sugar Refining Co., Ltd. Keratoconjunctival protecting agent, or keratoconjunctival disorder inhibiting agent
RU2522381C1 (ru) * 2013-01-24 2014-07-10 федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ лечения трофических эрозий роговицы
KR101692578B1 (ko) * 2013-04-18 2017-01-03 삼진제약주식회사 레바미피드 또는 이의 전구체를 포함하는 안구건조증의 예방 또는 치료를 위한 경구용 약제학적 조성물
RU2544225C1 (ru) * 2013-12-13 2015-03-10 федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ лечения послеоперационных эрозий роговицы после удаления птеригиума
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
CN108024831A (zh) 2015-10-23 2018-05-11 纽约市哥伦比亚大学理事会 由激光诱导的组织中的胶原交联
GB2550110A (en) * 2016-04-28 2017-11-15 Univ Oxford Innovation Ltd Treatment of impulsivity-related disorders
WO2017214604A1 (en) 2016-06-10 2017-12-14 The Trustees Of Columbia University In The City Of New York Devices, methods, and systems for detection of collagen tissue features
US11554104B2 (en) 2017-08-18 2023-01-17 The Schepens Eye Research Institute, Inc. Compositions for the treatment of dry eye and methods of use thereof
GB201717629D0 (en) 2017-10-26 2017-12-13 Univ Oxford Innovation Ltd Treatment of unipolar depressive disorder
US11666481B1 (en) 2017-12-01 2023-06-06 The Trustees Of Columbia University In The City Of New York Diagnosis and treatment of collagen-containing tissues

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3616923A1 (de) 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
US4778814A (en) 1987-03-18 1988-10-18 Ciba-Geigy Corporation Method of treating ocular allergy by topical application of a 2-substituted-1,2-benzisoselenazol-3(2H)-one
US6342510B1 (en) 1995-06-12 2002-01-29 G. D. Searle & Co. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitors and a leukotriene B4 receptor antagonist
FR2740339B1 (fr) 1995-10-26 1997-12-05 Oreal Utilisation d'au moins un inhibiteur de no-synthase dans le traitement des peaux sensibles
FR2757860B1 (fr) * 1996-12-27 1999-04-23 Oxis International Sa Composes organoselenies cycliques, leur preparation et leurs utilisations, notamment therapeutiques
JP2001261555A (ja) 2000-03-17 2001-09-26 Dai Ichi Seiyaku Co Ltd 脳動脈中膜肥厚抑制剤
FR2815541B1 (fr) * 2000-10-24 2008-02-29 Lipha Utilisation d'inhibiteurs de l'apoptose des pericytes pour le traitement et/ou la prevention de la retinopathie diabetique
TWI263505B (en) * 2001-11-19 2006-10-11 Sucampo Ag Pharmaceutical composition comprising a C1C-2 channel opener
WO2004069157A2 (en) * 2003-01-17 2004-08-19 Ophthalmic Research Associates, Inc. Combinational use of long-acting and short-acting anti-histamines for ocular allergies
WO2004071419A2 (en) 2003-02-07 2004-08-26 The General Hospital Corporation Methods and compositions for modulating glutamate transport activity in the nervous system
JP2006104199A (ja) * 2004-09-13 2006-04-20 Santen Pharmaceut Co Ltd 角結膜障害治療剤
RU2406499C2 (ru) 2005-05-17 2010-12-20 Сантен Фармасьютикал Ко., Лтд. Профилактическое или терапевтическое средство для лечения кератоконъюнктивитных нарушений
JP2008013448A (ja) 2006-07-03 2008-01-24 Gifu Prefecture 視神経細胞保護剤
ES2370751T3 (es) 2007-05-25 2011-12-22 Santen Pharmaceutical Co., Ltd Agente profiláctico o terapéutico para la degeneración macular asociada a la edad.
KR20100124756A (ko) 2008-02-28 2010-11-29 산텐 세이야꾸 가부시키가이샤 시신경 장해를 동반하는 안질환의 예방 또는 치료제

Also Published As

Publication number Publication date
PT1884234E (pt) 2012-07-26
WO2006123676A1 (ja) 2006-11-23
ES2389566T3 (es) 2012-10-29
RU2007146688A (ru) 2009-06-27
EP1884234B1 (en) 2012-07-18
KR20080016556A (ko) 2008-02-21
US8222283B2 (en) 2012-07-17
CN101175487A (zh) 2008-05-07
CA2608457A1 (en) 2006-11-23
DK1884234T3 (da) 2012-10-08
CY1113161T1 (el) 2016-04-13
RU2406499C2 (ru) 2010-12-20
PL1884234T3 (pl) 2012-11-30
US8536207B2 (en) 2013-09-17
NO20076398L (no) 2008-02-11
CA2608457C (en) 2013-09-10
US20120232119A1 (en) 2012-09-13
CN101175487B (zh) 2011-11-16
EP1884234A1 (en) 2008-02-06
EP1884234A4 (en) 2010-01-13
KR101286883B1 (ko) 2013-07-16
US20090105313A1 (en) 2009-04-23

Similar Documents

Publication Publication Date Title
EP1884234A4 (en) PROPHYLACTIC OR THERAPEUTIC AGENT FOR DISEASES OF CORNEAL AND BINDING SKIN
HK1218620A1 (zh) 眼用組合物和治療眼睛的方法
EP1861161A4 (en) APPARATUS AND METHOD FOR DISPENSING THERAPEUTIC AND / OR OTHER AGENTS IN THE INTERNAL EAR AND OTHER FABRICS
EP1776148A4 (en) OPHTHALMIC DEVICES AND METHODS AND COMPOSITIONS THEREFOR
EP1893216A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES
PL2444079T3 (pl) Kompozycje i sposoby leczenia chorób oczu
GB0521139D0 (en) Therapeutic agent
GB0516091D0 (en) Therapeutic agent
EP1915998A4 (en) PROPHYLACTIC OR THERAPEUTIC AGENT FOR CORNEAL OR CONJUNCTIVAL DISEASE
EP1905452A4 (en) AGENT FOR THE PREVENTION OR TREATMENT OF GLAUCOMA
EP1796675A4 (en) COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DISEASES
IL189009A0 (en) Methods and compositions for the treatment of neuropathies and related disorders
EP2069391A4 (en) COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING EYE DRYING
ZA200806881B (en) Therapeutic prophylactic ophthalmologic lens for pseudo-aphakic eyes and/or eyes suffering neurodegeneration
EP1894572A4 (en) THERAPEUTIC AND / OR PROPHYLACTIC AGGREGATE AGAINST NEUROGENIC PAIN
HK1138204A1 (en) Prophylactic or therapeutic agent for alopecia
EP1776956A4 (en) PREVENTIVE AND / OR THERAPEUTIC AGENT FOR CALCIPENIA
GB0508153D0 (en) Therapeutic agent
GB201013152D0 (en) Prophylactic and therapeutic agents and uses thereof
EP1872783A4 (en) THERAPEUTIC AGENT FOR CORNEAL / CONJUNCTIVAL DISORDER
EP1858557A4 (en) METHODS AND COMPOSITIONS FOR MODULATING BODY WEIGHT AND TREATING WEIGHT RELATED DISORDERS AND DISEASES
GB0408959D0 (en) Therapeutic agent
IL185684A0 (en) Methods and compositions for modulating body weight and for treating weight disorders and related diseases
GB0516732D0 (en) Therapeutic agent